Simultaneous Modeling of the Pharmacokinetic and Pharmacodynamic Properties of Benzodiazepines. II. Triazolam

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Pharmaceutical Research

• Publication date

  1990-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1023/A:1015805908792PMID 2367325
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Degree of sedation obtained with various doses of diazepam and nitrazepam.

  2009cited by this paper
• Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives

  2004cited by this paper
• Effects of lorazepam on memory, attention and sedation in man

  2004cited by this paper
• Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines I: Lorazepam

  1990cited by this paper
• Ventilatory effects of single, high‐dose triazolam in awake human subjects

  1988cited by this paper
• Comparative single‐dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo

  1988cited by this paper
• Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam.

  1988cited by this paper
• Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam.

  1987cited by this paper
• Nighttime Dosing of Triazolam in Patients with Liver Disease and Normal Subjects: Kinetics and Daytime Effects

  1987cited by this paper
• Pharmacodynamics of Triazolam After Intravenous Administration

  1987cited by this paper
• Lack of influence of cigarette smoking on triazolam pharmacokinetics.

  1987cited by this paper
• Relationships Between CSF Drug Concentrations, Receptor Binding Characteristics, and Pharmacokinetic and Pharmacodynamic Properties of Selected 1,4-Substituted Benzodiazepines

  1987cited by this paper
• Population study of triazolam pharmacokinetics.

  1986cited by this paper
• Hypnotics and sedatives

  1986cited by this paper
• Estimation of variance for harmonic mean half-lives.

  1985cited by this paper
• JANA: a new iterative polyexponential curve stripping program.

  1985cited by this paper
• Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability.

  1985cited by this paper
• The Influence of Obesity on the Pharmacokinetics of Oral Alprazolam and Triazolam

  1984cited by this paper
• Duration of benzodiazepine clinical activity: Lack of direct relationship with plasma half-life

  1984cited by this paper
• Drug Concentration, Binding, and Effect In Vivo

  1984cited by this paper
• Triazolam concentration‐effect relationships in healthy subjects

  1983cited by this paper
• Relationship between plasma concentration and effect of midazolam after oral and intravenous administration.

  1983cited by this paper
• New drug evaluations. Triazolam.

  1983cited by this paper
• Effects of clorazepate, diazepam, lorazepam, and placebo on human memory

  1983cited by this paper
• In vitro quantitation of benzodiazepine lipophilicity: relation to in vivo distribution.

  1983cited by this paper
• Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.

  1983cited by this paper
• Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam

  1983cited by this paper
• Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites.

  1983cited by this paper
• Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam.

  1983cited by this paper
• In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution.

  1983cited by this paper
• Determination of biological activity of alprazolam, triazolam and their metabolites

  1982cited by this paper
• Triazolam disposition

  1981cited by this paper
• Understanding the Dose-Effect Relationship

  1981cited by this paper
• Onset of peak impairment after diazepam and after alcohol

  1981cited by this paper
• Simultaneous pharmacokinetic and pharmacodynamic modeling

  1981cited by this paper
• Electron-capture gas chromatographic analysis of the triazolobenzodiazepines alprazolam and triazolam.

  1981cited by this paper
• Pharmacokinetic and pharmacodynamic modeling in vivo.

  1981cited by this paper
• The effects of triazolam and nitrazepam on sleep quality, morning vigilance and psychomotor performance.

  1980cited by this paper
• Benzodiazepines: Clinical Pharmacology and Therapeutic Use

  1980cited by this paper
• Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

  1980cited by this paper
• Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine

  1979cited by this paper
• Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations

  1978cited by this paper
• Determining Optimum Dose and Acute Tolerance of Triazolam

  1977cited by this paper
• Relative amnesic actions of diazepam, flunitrazepam and lorazepam in man.

  1977cited by this paper
• Effect of benzodiazepines upon saccadic eye movements in man

  1971cited by this paper
• Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man.

  1968cited by this paper

• Towards better fall prevention : Examining the interplay between factors that influence gait in older patients

  2017cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Anxiolytics and Sedative/Hypnotics

  2016cites this paper
• Effect of Extracorporeal Membrane Oxygenation Use on Sedative Requirements in Patients with Severe Acute Respiratory Distress Syndrome

  2016cites this paper
• Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

  2014cites this paper
• The Effects of Fall-Risk-Increasing Drugs on Postural Control: A Literature Review

  2013cites this paper
• Tissue distribution and pharmacodynamics: a complicated relationship.

  2006cites this paper
• Relationship between cerebral pharmacokinetics and anxiolytic activity of diazepam and its active metabolites after a single intra‐peritoneal administration of diazepam in mice

  2002cites this paper
• Mechanisms influencing stimulus-response properties of the human corticospinal system.

  2001cites this paper
• Detection of triazolam and its hydroxy metabolites in rat hair by reversed-phase liquid chromatography with electrospray ionization mass spectrometry.

  2000cites this paper
• A Randomized Clinical Trial of Triazolam in 3- to 5-year-olds

  1999cites this paper
• Do Alprazolam‐Induced Changes in Saccadic Eye Movement and Psychomotor Function Follow the Same Time Course?

  1998cites this paper
• Human variability and noncancer risk assessment--an analysis of the default uncertainty factor.

  1998cites this paper
• Pharmacokinetics and Psychomotor Performance of Alprazolam: Concentration—Effect Relationship

  1997cites this paper
• Anticonvulsant pharmacodynamics and disposition of triazolam in rats.

  1996cites this paper
• Pharmacokinetic-Pharmacodynamic Relationships For Benzodiazepines

  1996cites this paper
• Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: Kinetic‐dynamic studies

  1994cites this paper
• Triazolam blood concentrations in forensic cases in Canada.

  1993cites this paper
• Comparison of the relationship between structure and CNS effects for lorazepam, clonazepam and alprazolam

  1993cites this paper
• Kinetic-dynamic modeling in clinical psychopharmacology.

  1993cites this paper
• Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant.

  1993cites this paper
• In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.

  1992cites this paper
• Benzodiazepines: use, abuse, and consequences.

  1992cites this paper
• Drug metabolism and interactions in abuse liability assessment.

  1991cites this paper
• Physiological pharmacokinetic and pharmacodynamic model of physostigmine in the rat.

  1991cites this paper
• Electroencephalographic effects of benzodiazepines. I. Choosing an electroencephalographic parameter to measure the effect of midazolam on the central nervous system

  1990cites this paper